THRA Antikörper (N-Term)
Kurzübersicht für THRA Antikörper (N-Term) (ABIN2375052)
Target
Alle THRA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Hund, Maus, Ratte (Rattus)
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Ca Mo Rt
-
Produktmerkmale
- Thyroid Hormone Receptor, alpha 1, alpha 2
-
Aufreinigung
- Purified by Protein G affinity chromatography.
-
Immunogen
- Peptide corresponding to amino acid residues from the N-terminal region of human thyroid hormone receptor, alpha1/alpha2 isotype.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in 10 mM Hepes, pH 7.5, 0.01 % BSA, 0.09 % sodium azide, 150 mM NaCl, 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- THRA (Thyroid Hormone Receptor, alpha (THRA))
-
Andere Bezeichnung
- Thyroid Hormone Receptor alpha 2
-
Pathways
- Nuclear Receptor Transcription Pathway, Steroid Hormone Mediated Signaling Pathway, Sensory Perception of Sound, Cellular Response to Molecule of Bacterial Origin, Regulation of Lipid Metabolism by PPARalpha, Regulation of Muscle Cell Differentiation, Maintenance of Protein Location, Skeletal Muscle Fiber Development
Target
-